Vertaling van "use and risk " (Frans → Nederlands) :

To asses the effects of poorer outcomes, we added the peri-procedural mortality of low volume centres in the US, using the observed risk ratio of death to the risks of stroke or death; low volume centres showed a 1.8 times higher peri-procedural mortality. 50
To asses the effects of poorer outcomes, we added the peri-procedural mortality of low volume centres in the US, using the observed risk ratio of death to the risks of stroke or death; low volume centres showed a 1.8 times higher peri-procedural mortality.[50]

Ce serait surtout le cas lors de l’utilisation de doses élevées et de traitement de longue durée. [FDA Drug safety communication: possible increased risk of fractures of the hip, wrist and spine with the use of proton pump inhibitors.
Dit zou vooral het geval zijn bij hogere doses en langere behandelingsduur [FDA Drug safety communication: possible increased risk of fractures of the hip, wrist and spine with the use of proton pump inhibitors.

Il est fait référence aux recommandations de la Guideline on Risk Management Systems for Medicinal Products for Human Use (EMEA/CHMP/96268/2005, annexe B, 1.4) : « en limitant le nombre d’unités, le patient devra voir un professionnel de la santé à des intervalles définis, augmentant ainsi les occasions d’être examiné et réduisant la durée durant laquelle un patient n’est pas examiné. Une petite taille de conditionnement peut également être utile, en particulier si l’on considère qu’il existe un risque majeur de surdose ou s’il faut restreindre la possibilité que les médicaments arrivent aux mains du grand public.
Er wordt verwezen naar de aanbevelingen van de Richtlijn betreffende risicobeheersystemen voor geneesmiddelen voor menselijk gebruik (EMEA/CHMP/96268/2005, bijlage B, 1.4): " door het aantal eenheden te beperken moet de patiënt op welbepaalde tijdstippen een gezondheidszorgbeoefenaar raadplegen waardoor er meer kans is om hem te testen en waardoor de tijdspanne waarin de patiënt zonder toezicht is, ingekort wordt... Een kleine verpakkingsgrootte kan ook nuttig zijn, in het bijzonder als er een groot risico van overdosering is of als de kans dat de drugs bij de algemene bevolking terechtkomen, moet worden beheerst”.

During the use of Bupropion immediate release (IR) at dosages higher than 300 mg per day, there is an increased risk of seizures 10 .
During the use of bupropion immediate release (IR) at dosages higher than 300 mg per day, there is an increased risk of seizures 10 .

D’après D.M. Grabrick et al.: Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.
Naar D.M. Grabrick et al.: Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.

Dial S, Delaney JAC, Barkun AN et Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.
Dial S, Delaney JAC, Barkun AN en Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Oral contraceptive use as a risk factor for premenopausal
Oral contraceptive use as a risk factor for premenopausal breast cancer:

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing
Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone

DE - Guidance on risk assessment of nanomaterials use at work 19/06/2012
DE - Guidance on risk assessment of nanomaterials use at work 19-06-2012

For families at risk, provide home-based educational interventions to help proactively to improve parenting skills, health behaviour and interaction between parents and children. vii. Set up in partnership with other ministers evidence-based education programmes addressing suicide, depression, alcohol and other substance use disorders for young people at schools and universities and involve role models and young people in the making of campaigns. viii.
Set up in partnership with other ministers evidence-based education programmes addressing suicide, depression, alcohol and other substance use disorders for young people at schools and universities and involve role models and young people in the making of campaigns. viii.